MALVERN, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy ...
TD Cowen 46th Annual Health Care Conference March 2, 2026 9:50 AM ESTCompany ParticipantsScott Ullem - Corporate ...
ZEELAND, MI, UNITED STATES, February 26, 2026 /EINPresswire.com/ — The Additive Manufacturing Users Group (AMUG) today announced a second keynote presentation for ...
SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the 47th Annual Raymond James Institutional Investors Conference on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results